ID
15373
Beschrijving
Study documentation part: Study medication Study short name: DIMAT MS Study Details: A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on ImmuneModulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis. Principal Investigator PD Dr. Luisa Klotz, University Hospital Münster EudraCT - No.: 2014-003481-25. Clinical Trial No.r: NCT02461069. Please document below only temporary changes in the dosing schedule. If the Study Medication is permanently discontinued, please complete the Discontinuation of Study Medication Form on page 33.
Trefwoorden
Versies (1)
- 28-05-16 28-05-16 -
Geüploaded op
28 mei 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Study medication, DIMAT-MS, Relapsing Remitting Multiple Sclerosis DRKS00008037 NCT02461069
Study medication, DIMAT-MS, Relapsing Remitting Multiple Sclerosis NCT02461069
Beschrijving
Signature
Similar models
Study medication, DIMAT-MS, Relapsing Remitting Multiple Sclerosis NCT02461069
C3556178 (UMLS CUI [1,2])
C3556178 (UMLS CUI [1,2])
C0449788 (UMLS CUI [1,2])
C0456081 (UMLS CUI [1,2])
C2826232 (UMLS CUI [1,2])
C0392360 (UMLS CUI [2,1])
C1512900 (UMLS CUI [2,2])
C0011008 (UMLS CUI [1,2])